14.12.2022 • News

French Farmer Wins €11,000 in Bayer Herbicide Lawsuit

A French farmer who said he suffered neurological problems including memory loss, fainting and headaches after inhaling fumes from Bayer’s Lasso-branded herbicide in an agricultural accident, has won compensation of €11,135, ending more than 15 years of litigation.

Lasso, another product Bayer inherited in its 2018 takeover of Monsanto, has since been withdrawn from the market. In 2019, the German group lost its last appeal in the long-running dispute, paving the way for the settlement.

Both the award and the coverage of the litigation pale in comparison with the much higher-profile cases in which US Roundup users have charged that the former Monsanto’s glyphosate-based herbicide caused their cancer. Those awards, which Bayer is still contesting, have run into the tens of millions of dollars.

Paul Francois, who was supported by French anti-pesticide campaigners, said he was disappointed with the the size of the payout, as his case points to a wider trend of illness caused by farm chemicals. "11,000 euros for so much sacrifice," the farmer told local and national media.

© Bayer
© Bayer

Bayer France and the farmer’s lawyer, Francois Lafforgue, told news agencies that the court’s experts had considered the accident as causing post-traumatic stress and that the award covered a temporary functional deficit and suffering endured by the plaintiff.

Bayer France said the sum awarded was less than 1% of what Francois had demanded, boosting media reports that he had asked for more than €1 million in compensation.

The agrochemicals multinational added that the court’s experts had not recognized any of the "serious pathologies" the farmer said he suffered from.  

Author: Dede Williams, Freelance Journalist

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.